Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Myrto Moutafi

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 2021
Putting the Microenvironment into the Immunotherapy Companion DiagnosticMyrto Moutafi, David L Rimm
Oral Oncology|April 16, 2021
PARP inhibitors in head and neck cancer: Molecular mechanisms, preclinical and clinical dataMyrto Moutafi, Panagiota Economopoulou, David Rimm, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 11, 2021
Standardization of PD-L1 immunohistochemistrySandra Martinez-Morilla, Myrto Moutafi, David L Rimm
International Journal of Molecular Sciences|April 12, 2022
Histone Deacetylase (HDAC) Inhibitors: A Promising Weapon to Tackle Therapy Resistance in MelanomaKostas Palamaris, Myrto Moutafi, Hariklia Gakiopoulou, et al.
Life (Basel, Switzerland)|June 27, 2024
Overcoming Resistance to Temozolomide in Glioblastoma: A Scoping Review of Preclinical and Clinical DataDimitra Smerdi, Myrto Moutafi, Ioannis Kotsantis, et al.
Frontiers in Oncology|October 5, 2020
The Genomic Profile of Pregnancy-Associated Breast Cancer: A Systematic ReviewAnna-Maria Korakiti, Myrto Moutafi, Eleni Zografos, et al.
Experimental and Therapeutic Medicine|February 24, 2025
Harlequin syndrome in a young patient with osteosarcoma after pleural metastasectomy: A case report and a mini review of the literatureMyrto Moutafi, Anastasios Kyriazoglou, Ioannis Kotsantis, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 27, 2023
Multiplex Immunohistochemistry and Immunofluorescence: A Practical Update for PathologistsPaul W Harms, Timothy L Frankel, Myrto Moutafi, et al.
Anticancer Research|July 26, 2024
Implications of the Hippo Pathway Dysregulation in Uterine LeiomyosarcomaAnastasios Kyriazoglou, Dionysios J Papachristou, Myrto Moutafi, et al.
Frontiers in Oncology|October 31, 2022
Location matters: LAG3 levels are lower in renal cell carcinoma metastatic sites compared to primary tumors, and expression at metastatic sites only may have prognostic importanceDavid A Schoenfeld, Ross D Merkin, Myrto Moutafi, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 2021
Putting the Microenvironment into the Immunotherapy Companion DiagnosticMyrto Moutafi, David L Rimm
Oral Oncology|April 16, 2021
PARP inhibitors in head and neck cancer: Molecular mechanisms, preclinical and clinical dataMyrto Moutafi, Panagiota Economopoulou, David Rimm, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 11, 2021
Standardization of PD-L1 immunohistochemistrySandra Martinez-Morilla, Myrto Moutafi, David L Rimm
International Journal of Molecular Sciences|April 12, 2022
Histone Deacetylase (HDAC) Inhibitors: A Promising Weapon to Tackle Therapy Resistance in MelanomaKostas Palamaris, Myrto Moutafi, Hariklia Gakiopoulou, et al.
Life (Basel, Switzerland)|June 27, 2024
Overcoming Resistance to Temozolomide in Glioblastoma: A Scoping Review of Preclinical and Clinical DataDimitra Smerdi, Myrto Moutafi, Ioannis Kotsantis, et al.
Frontiers in Oncology|October 5, 2020
The Genomic Profile of Pregnancy-Associated Breast Cancer: A Systematic ReviewAnna-Maria Korakiti, Myrto Moutafi, Eleni Zografos, et al.
Experimental and Therapeutic Medicine|February 24, 2025
Harlequin syndrome in a young patient with osteosarcoma after pleural metastasectomy: A case report and a mini review of the literatureMyrto Moutafi, Anastasios Kyriazoglou, Ioannis Kotsantis, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 27, 2023
Multiplex Immunohistochemistry and Immunofluorescence: A Practical Update for PathologistsPaul W Harms, Timothy L Frankel, Myrto Moutafi, et al.
Anticancer Research|July 26, 2024
Implications of the Hippo Pathway Dysregulation in Uterine LeiomyosarcomaAnastasios Kyriazoglou, Dionysios J Papachristou, Myrto Moutafi, et al.
Frontiers in Oncology|October 31, 2022
Location matters: LAG3 levels are lower in renal cell carcinoma metastatic sites compared to primary tumors, and expression at metastatic sites only may have prognostic importanceDavid A Schoenfeld, Ross D Merkin, Myrto Moutafi, et al.
Pageof 4